Deutetrabenazine for the treatment of Huntington’s chorea
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2018.1500178
Abstract: ABSTRACT Introduction: Huntington’s disease (HD) is an inherited neurodegenerative disorder for which no disease-modifying treatment is currently available. Only symptomatic treatment can be offered. Chorea is the most common motor manifestation of HD and may… read more here.
Keywords: treatment; huntington; deutetrabenazine treatment; chorea ... See more keywords
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
Sign Up to like & getrecommendations! Published in 2018 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s138828
Abstract: Deutetrabenazine was recently approved for the treatment of chorea in Huntington’s disease (HD) and is the first deuterated medication that has been US Food and Drug Administration (FDA)-approved for therapeutic use. In this article, we… read more here.
Keywords: huntington disease; treatment; drug; deutetrabenazine ... See more keywords